Ovation Fertility
Ovation Fertility is a prominent provider of comprehensive fertility services, operating 14 IVF labs across 10 states and known for its advanced practices and high pregnancy rates.
Fertility Services
Ovation Fertility offers a comprehensive range of fertility services. These include in vitro fertilization (IVF), genetic testing, egg donation, and surrogacy. They also provide advanced IVF services known for their high pregnancy rates and state-of-the-art practices. Ancillary services include donor eggs, gestational surrogacy, and storage for frozen reproductive materials. This extensive offering ensures that patients have access to a full spectrum of reproductive options.
IVF Labs
Ovation Fertility operates 14 IVF labs across 10 states. These labs are equipped to provide cutting-edge fertility treatments and services. Each lab is staffed by skilled professionals who utilize standardized best practices to ensure quality and consistency in patient care. This network allows for a wide reach, supporting patients from various locations with top-tier reproductive services.
Research and Innovation
Ovation Fertility employs renowned scientists who are known for their significant contributions to fertility research. The company actively collaborates on award-winning research projects, which help in advancing the field of reproductive medicine. This focus on research and innovation allows Ovation Fertility to continuously improve and offer advanced treatment options to its patients.
Affiliation Model
Ovation Fertility offers a unique affiliation model designed for physicians. This model allows physicians to benefit from being part of a larger fertility platform while maintaining their practice’s autonomy. This collaborative approach ensures access to extensive resources and support from a leading reproductive healthcare network.
Corporate Backing
Ovation Fertility is backed by Morgan Stanley Capital Partners. This partnership provides a strong financial foundation, allowing Ovation Fertility to invest in advanced technologies and expand their services. This backing underscores the company’s stability and growth potential in the field of reproductive medicine.